About Beijing Foyou Pharma Company

Yuan Pharmaceutical will be listed on June 30, 2022, stock code 601089. The company is mainly engaged in R&D, production and sales of pharmaceutical preparations and medical devices. With the mission of “focusing on the pharmaceutical field and creating a healthy life”, the company is committed to building a core competitive advantage integrating R&D, production and sales, continuously building a large-scale product group, forming a rich product line with combined advantages of “field, variety and technology”, and constructing an industrial value chain from raw materials to the complete cycle of pharmaceuticals. The company has been selected as a G20 enterprise for leapfrog development projects in the Beijing pharmaceutical industry, ranked among China's top 100 chemical research and development capabilities, and received wide recognition from within and outside the industry. The company is mainly engaged in R&D, production and sales of pharmaceutical preparations and medical devices, and its products have strong competitiveness and high market recognition. The company has a rich product range. Currently, pharmaceutical preparations mainly cover various product segments such as cardiovascular system, chronic nephropathy, skin disease, digestive system, diabetes, neuropsychiatric system, gynecology, etc. It has losartan potassium hydrochlorothiazide tablets, omesartan ester tablets, telmisartan tablets, trimetazidine hydrochloride tablets, atorvastatin calcium tablets, compound α-ketoacid tablets, hassinide solution, pivivirimonium bromide tablets, cesel, regrenone tablets, etc. A number of major products such as acarboxide tablets, paroxetine hydrochloride tablets, venlafaxine hydrochloride sustained-release capsules, progesterone softgels, etc.; Report During the period, the company's medical device business was mainly humidified oxygen absorption devices, and its main products included disposable oxygen intake tubes, etc. Company Honors: Beijing Biomedical Industry Leapfrog Development Project (G20) - Industry Leading Enterprise, High-tech Enterprise.